SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 24th, 2020 • Therapix Biosciences Ltd. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 19, 2020, by and between THERAPIX BIOSCIENCES LTD., with headquarters located at 4 Ariel Sharon St., Hashahar Tower, 16th Floor, Givatayim 5320047, Israel (the “Company”) and DEKEL PHARMACEUTICALS LTD., with its address at 20 Yoav Street, Tel-Aviv, Israel 690815 (the “Buyer”).
ContractTherapix Biosciences Ltd. • March 24th, 2020 • Pharmaceutical preparations • New York
THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION.
